This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (4)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Retinal/ Chorioretinal Disorders  • Ocular Imaging  • Alert me on articles by topic

Arch Ophthalmol. 2005;123:1746-1750.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Combined hamartoma of the retina and retinal pigment epithelium (RPE) is an uncommon fundus tumor with classic clinical features.¹ In 1984, Schachat et al² published 60 cases collected from the members of the Macula Society and described the clinical features and natural course of this benign lesion. They noted that the lesion was typically pigmented (52 cases [87%]), elevated (48 cases [80%]), and had vascular tortuosity (56 cases [93%]), vitreoretinal interface changes (47 cases [78%]), and lipid exudate (4 cases [7%]). The vitreoretinal interface changes in that series of patients were appreciated on ophthalmoscopic examination as surface wrinkling retinopathy and also, to some extent, were inferred based on fluorescein angiography as vascular dragging. In their series, progressive loss of visual acuity due to tractional distortion of the fovea from vitreoretinal interface problems was observed in 14 (24%) of 60 cases. The importance of the vitreoretinal interface in this condition and . . . [Full Text of this Article]

Methods


Results

Comment

AUTHOR INFORMATION
Carol L. Shields, MD; Arman Mashayekhi, MD; Vicktoria V. Dai, MD; Miguel A. Materin, MD; Jerry A. Shields, MD